100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothGlimepiride 2mg + Metformin 500mg + Voglibose 0.2mg
You Searched
Our Recommendation
Glimda MV 2/500/0.2mg SR Tablet 10s
5,840+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Type 2 diabetes mellitus
Customers also bought
More About Glyphase-MV 2/0.2 Tablet SR
Side Effects
Side effects of Glyphase MV Tablet SRThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Glyphase MVHypoglycemia (low blood glucose level)Nausea Abdominal pain Constipation
How to use
How to use Glyphase MV Tablet SRFollow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Glyphase-MV 2/0.2 Tablet SR is to be taken with food.
How it works
How Glyphase MV Tablet SR works Glyphase-MV 2/0.2 Tablet SR is a combination of three antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Glyphase-MV 2/0.2 Tablet SR as it is deemed unsafe.
Glyphase-MV 2/0.2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Glyphase-MV 2/0.2 Tablet SR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Glyphase-MV 2/0.2 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glyphase-MV 2/0.2 Tablet SR may be needed. Doctor consultation is advised.Use of Glyphase-MV 2/0.2 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Glyphase-MV 2/0.2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glyphase-MV 2/0.2 Tablet SR may be needed. Doctor consultation is advised.Glyphase-MV 2/0.2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
References
Glimepiride (08 Apr. 2019)
Metformin hydrochloride (08 Apr. 2019)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Glimepiride+Metformin+Voglibose (25 Oct. 2021)
Metformin Hydrochloride (Prolonged Release), Voglibose & Glimepiride (28th Sept. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
